K. Stuart, R. Brun, S. Croft, A. Fairlamb, and R. Gurtler, Kinetoplastids: related protozoan pathogens, different diseases, Journal of Clinical Investigation, vol.118, issue.4, pp.1301-1310, 2008.
DOI : 10.1172/JCI33945

R. Reithinger, J. Dujardin, H. Louzir, C. Pirmez, and B. Alexander, Cutaneous leishmaniasis, The Lancet Infectious Diseases, vol.7, issue.9, pp.581-596, 2007.
DOI : 10.1016/S1473-3099(07)70209-8

S. Croft, S. Sundar, and A. Fairlamb, Drug Resistance in Leishmaniasis, Clinical Microbiology Reviews, vol.19, issue.1, pp.111-126, 2006.
DOI : 10.1128/CMR.19.1.111-126.2006

F. Modabber, P. Buffet, E. Torreele, G. Milon, and S. Croft, Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis, Institute Pasteur Kinetoplastid Biol Dis, vol.6, pp.13-15, 2006.

A. Khatami, A. Firooz, F. Gorouhi, and Y. Dowlati, Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials, Journal of the American Academy of Dermatology, vol.57, issue.2, pp.335-329, 2007.
DOI : 10.1016/j.jaad.2007.01.016

A. Khamesipour, S. Rafati, N. Davoudi, F. Maboudi, and F. Modabber, Leishmaniasis vaccine candidates for development: a global overview, Indian J Med Res, vol.123, pp.423-438, 2006.

S. Noazin, A. Khamesipour, L. Moulton, M. Tanner, and K. Nasseri, Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis???A meta-analysis, Vaccine, vol.27, issue.35, pp.4747-4753, 2009.
DOI : 10.1016/j.vaccine.2009.05.084

R. Locksley, F. Heinzel, M. Sadick, B. Holaday, K. Gardner et al., Murine cutaneous leishmaniasis : Susceptibility correlates with differential expansion of helper T-cell subsets, Annales de l'Institut Pasteur / Immunologie, vol.138, issue.5, pp.744-749, 1987.
DOI : 10.1016/S0769-2625(87)80030-2

D. Sacks and N. Noben-trauth, The immunology of susceptibility and resistance to leishmania major in mice, Nature Reviews Immunology, vol.2, issue.11, pp.845-858, 2002.
DOI : 10.1038/nri933

S. Ajdary, M. Alimohammadian, M. Eslami, K. Kemp, and A. Kharazmi, Comparison of the Immune Profile of Nonhealing Cutaneous Leishmaniasis Patients with Those with Active Lesions and Those Who Have Recovered from Infection, Infection and Immunity, vol.68, issue.4, pp.1760-1764, 2000.
DOI : 10.1128/IAI.68.4.1760-1764.2000

L. Castellano, D. Filho, L. Argiro, H. Dessein, and A. Prata, Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-?? production, Human Immunology, vol.70, issue.6, pp.383-390, 2009.
DOI : 10.1016/j.humimm.2009.01.007

G. Habibi, A. Khamesipour, W. Mcmaster, and F. Mahboudi, Cytokine Gene Expression in Healing and Non-Healing Cases of Cutaneous Leishmaniasis in Response to In vitro Stimulation with Recombinant gp63 Using Semi-Quantitative RT-PCR, Scandinavian Journal of Immunology, vol.147, issue.4, pp.414-420, 2001.
DOI : 10.1016/S0952-7915(96)80040-9

M. Mahmoodi, A. Khamesipour, Y. Dowlati, S. Rafati, and A. Momeni, Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG, Clinical and Experimental Immunology, vol.21, issue.2, pp.303-308, 2003.
DOI : 10.1016/0022-1759(87)90497-2

N. Rostami, M. Khamesipour, A. Eskandari, S. , M. Mohammadi et al., Flow cytometric analysis of Leishmania reactive CD4+/CD8+ lymphocyte proliferation in cutaneous leishmaniasis, Iranian J Parasitol, vol.3, pp.9-18, 2008.

J. Ruiz and I. Becker, CD8 cytotoxic T cells in cutaneous leishmaniasis, Parasite Immunology, vol.152, issue.12, pp.671-678, 2007.
DOI : 10.1084/jem.174.3.499

G. Caceres-dittmar, F. Tapia, M. Sanchez, M. Yamamura, and K. Uyemura, Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction, Clinical & Experimental Immunology, vol.8, issue.3, pp.500-505, 1993.
DOI : 10.1111/j.1365-2249.1993.tb05931.x

M. Castes, M. Cabrera, D. Trujillo, and J. Convit, T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis, J Clin Microbiol, vol.26, pp.1207-1213, 1988.

K. Rogers and R. Titus, THE HUMAN CYTOKINE RESPONSE TO LEISHMANIA MAJOR EARLY AFTER EXPOSURE TO THE PARASITE IN VITRO, Journal of Parasitology, vol.90, issue.3, pp.557-563, 2004.
DOI : 10.1645/GE-3317

S. Parker, C. Roberts, and A. J. , CD8+ T cells are the major lymphocyte subpopulatlon involved in the protective immune response to Toxoplasma gondii in mice, Clinical & Experimental Immunology, vol.138, issue.2, pp.207-212, 1991.
DOI : 10.1111/j.1365-2249.1991.tb08150.x

Y. Suzuki, Immunopathogenesis of Cerebral Toxoplasmosis, The Journal of Infectious Diseases, vol.186, issue.s2, pp.234-240, 2002.
DOI : 10.1086/344276

J. Hafalla, I. Cockburn, and F. Zavala, Protective and pathogenic roles of CD8+ T cells during malaria infection, Parasite Immunology, vol.173, issue.1-2, pp.15-24, 2006.
DOI : 10.1186/1475-2875-2-6

M. Miyakoda, D. Kimura, M. Yuda, Y. Chinzei, and Y. Shibata, Malaria-Specific and Nonspecific Activation of CD8+ T Cells during Blood Stage of Plasmodium berghei Infection, The Journal of Immunology, vol.181, issue.2, pp.1420-1428, 2008.
DOI : 10.4049/jimmunol.181.2.1420

A. Mcmichael and T. Hanke, OPINION ??? VACCINES: The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?, Nature Reviews Immunology, vol.71, issue.4, pp.283-291, 2002.
DOI : 10.1038/nm1201-1320

A. Mcmichael, G. Ogg, J. Wilson, M. Callan, and S. Hambleton, Memory CD8+ T cells in HIV infection, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.355, issue.1395, pp.363-367, 2000.
DOI : 10.1098/rstb.2000.0575

L. Papagno, C. Spina, A. Marchant, M. Salio, and N. Rufer, Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection, PLoS Biology, vol.195, issue.2, p.20, 2004.
DOI : 10.1371/journal.pbio.0020020.t001

N. Gulzar and K. Copeland, CD8+ T-Cells: Function and Response to HIV Infection, Current HIV Research, vol.2, issue.1, pp.23-37, 2004.
DOI : 10.2174/1570162043485077

M. Lara-tejero and E. Pamer, T cell responses to Listeria monocytogenes, Current Opinion in Microbiology, vol.7, issue.1, pp.45-50, 2004.
DOI : 10.1016/j.mib.2003.12.002

S. Herath, P. Kropf, and I. Muller, Cross-talk between CD8+ and CD4+ T cells in experimental cutaneous leishmaniasis: CD8+ T cells are required for optimal IFN-gamma production by CD4+ T cells, Parasite Immunology, vol.60, issue.11-12, pp.559-567, 2003.
DOI : 10.1146/annurev.immunol.20.100301.064828

I. Muller, P. Kropf, R. Etges, and J. Louis, Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells, Infect Immun, vol.61, pp.3730-3738, 1993.

P. Tsagozis, E. Karagouni, and E. Dotsika, CD8+ T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis, Parasite Immunology, vol.171, issue.11-12, pp.569-579, 2003.
DOI : 10.1084/jem.181.1.387

J. Uzonna, K. Joyce, and P. Scott, T Cells, The Journal of Experimental Medicine, vol.162, issue.11, pp.1559-1566, 2004.
DOI : 10.1038/nature01152

R. Bittar, R. Nogueira, R. Vieira-goncalves, V. Pinho-ribeiro, and M. Mattos, T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis, Mem??rias do Instituto Oswaldo Cruz, vol.102, issue.5, pp.625-630, 2007.
DOI : 10.1590/S0074-02762007005000069

S. Coutinho, A. Da-cruz, A. Bertho, M. Santiago, and P. De-luca, Immunologic patterns associated with cure in human American cutaneous leishmaniasis, Brazilian Journal of Medical and Biological Research, vol.31, issue.1, pp.139-142, 1998.
DOI : 10.1590/S0100-879X1998000100019

A. Da-cruz, A. Bertho, M. Oliveira-neto, and S. Coutinho, Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions, British Journal of Dermatology, vol.272, issue.3, pp.537-543, 2005.
DOI : 10.1111/j.1365-2133.2005.06647.x

A. Da-cruz, R. Bittar, M. Mattos, M. Oliveira-neto, and R. Nogueira, T-Cell-Mediated Immune Responses in Patients with Cutaneous or Mucosal Leishmaniasis: Long-Term Evaluation after Therapy, Clinical and Vaccine Immunology, vol.9, issue.2, pp.251-256, 2002.
DOI : 10.1128/CDLI.9.2.251-256.2002

N. Rostami, M. Keshavarz, H. Khamesipour, and A. , Immune response of BALB/c mice against an experimental vaccine of Alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae, Trop Biomed, vol.27, pp.89-102, 2010.

P. Scott, P. Natovitz, R. Coffman, E. Pearce, and A. Sher, CD4+ T cell subsets in experimental cutaneous leishmaniasis, Mem??rias do Instituto Oswaldo Cruz, vol.83, issue.1, pp.256-259, 1988.
DOI : 10.1590/S0074-02761988000500006

K. Kemp, T. Theander, L. Hviid, A. Garfar, and A. Kharazmi, Interferon-??- and Tumour Necrosis Factor-??-Producing Cells in Humans who are Immune to Cutaneous Leishmaniasis, Scandinavian Journal of Immunology, vol.62, issue.6, pp.655-659, 1999.
DOI : 10.1046/j.1365-3083.1999.00554.x

S. Coutinho, C. Pirmez, and A. Da-cruz, Parasitological and immunological follow-up of American tegumentary leishmaniasis patients, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.96, issue.1, pp.173-178, 2002.
DOI : 10.1016/S0035-9203(02)90072-6

G. Bomfim, B. Andrade, S. Santos, J. Clarencio, and M. Barral-netto, Cellular analysis of cutaneous leishmaniasis lymphadenopathy: insights into the early phases of human disease, Am J Trop Med Hyg, vol.77, pp.854-859, 2007.

D. Faria, P. Souza, F. Duraes, E. Carvalho, and K. Gollob, T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis, Parasite Immunology, vol.63, issue.8, pp.432-439, 2009.
DOI : 10.1111/j.1365-3024.2009.01125.x

M. Huber, E. Timms, T. Mak, M. Rollinghoff, and M. Lohoff, Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice, Infect Immun, vol.66, pp.3968-3970, 1998.

Y. Belkaid, S. Von, S. Mendez, R. Lira, and E. Caler, CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major, The Journal of Immunology, vol.168, issue.8, pp.3992-4000, 2002.
DOI : 10.4049/jimmunol.168.8.3992

A. Gaafar, B. Veress, H. Permin, A. Kharazmi, and T. Theander, Characterization of the Local and Systemic Immune Responses in Patients with Cutaneous Leishmaniasis Due toLeishmania major, Clinical Immunology, vol.91, issue.3, pp.314-320, 1999.
DOI : 10.1006/clim.1999.4705

O. Bacellar, H. Lessa, A. Schriefer, P. Machado, and J. Ribeiro-de, Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients, Infection and Immunity, vol.70, issue.12, pp.6734-6740, 2002.
DOI : 10.1128/IAI.70.12.6734-6740.2002

R. Bottrel, W. Dutra, F. Martins, B. Gontijo, and E. Carvalho, Flow Cytometric Determination of Cellular Sources and Frequencies of Key Cytokine-Producing Lymphocytes Directed against Recombinant LACK and Soluble Leishmania Antigen in Human Cutaneous Leishmaniasis, Infection and Immunity, vol.69, issue.5, pp.3232-3239, 2001.
DOI : 10.1128/IAI.69.5.3232-3239.2001

E. Carvalho, F. Correia, O. Bacellar, R. Almeida, and H. Lessa, Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis, Am J Trop Med Hyg, vol.53, pp.273-277, 1995.

L. Reis, M. Brito, M. Souza, A. Medeiros, and C. Silva, Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment, Journal of Clinical Laboratory Analysis, vol.420, issue.1, pp.63-69, 2009.
DOI : 10.1002/jcla.20291